Mikhail Blagosklonny is an Oncologist and Research Scientist

Mikhail Blagosklonny is a university professor, philanthropist, and research scientist. He has previously told the press that he sincerely hopes that someday he will have the ability to guarantee that everyone on the planet will be able to easily access the best, most up-to-date medical treatment available regardless of their personal finances. He is especially interested in the field of medical research.

Blagosklonny is focused on studying aging and cancer both. He is especially concerned with the relation between aging and cancer. He is always working towards learning why cancer is significantly more common in adult patients past a certain age.

Blagosklonny has a theory on the potential role that TOR signaling plays in aging and cancer. He believes that the well-known cancer drug, rapamycin, may also be used as not only a cancer treatment but as a way of extending life. This is one of several reasons why Mikhail Blagosklonny is to be one of the most active advocates for using the drug rapamycin in the field of longevity research. Know more about Mikhail at Philly Purge.

Research

Today Blagosklonny is conducting studies that he believes will always be helpful in the field of oncology. As a university professor, research scientist, and an expert in his field, Blagosklonny also continues to influence others. Various sources also report that he is a continued source of inspiration to not only his co-workers but his pupils who long to one day in the future take his research to the next step.

Fields Of Interest

His particular areas of interest in the general fields of aging and cancer have garnered quite a lot of attention from other individuals working in the field of medicine. Blagosklonny’s main goal is to not only determine just how to treat cancer but also to learn how to treat it effectively but also painlessly and less expensively than any cancer treatments currently in use today. He is striving to discover just how to eliminate cancerous cells in a person’s body without destroying any of the thriving, healthy, normal cells that are essential to the overall healing process of the body and mind following the many months or sometimes years of cancer treatment. Visit ResearchGate.Net to know more about Mikhail’s latest work.

Other Activities

Mikhail Blagosklonny is also serving as one of the editors-in-chief of “Cell Cycle”, “Oncotarget”, and “Aging.” He is also a member of the editorial board of “Cell Death & Differentiation” and an associate editor for “Cancer Biology & Therapy.”

Know more: https://www.crunchbase.com/person/mikhail-blagosklonny